Comparative immune profiling of pancreatic ductal adenocarcinoma progression among South African patients DOI Creative Commons

Nnenna Elebo,

Ebtesam A. Abdel-Shafy, J. Omoshoro–Jones

et al.

BMC Cancer, Journal Year: 2024, Volume and Issue: 24(1)

Published: July 7, 2024

Pancreatic Ductal Adenocarcinoma (PDAC) is an aggressive cancer characterized by immunosuppressive microenvironment. Patients from specific ethnicities and population groups have poorer prognoses than others. Therefore, a better understanding of the immune landscape in such necessary for disease elucidation, predicting patient outcomes therapeutic targeting. This study investigated expression circulating key cell markers South African PDAC patients ancestry.

Language: Английский

Comparative immune profiling of pancreatic ductal adenocarcinoma progression among South African patients DOI Creative Commons

Nnenna Elebo,

Ebtesam A. Abdel-Shafy, J. Omoshoro–Jones

et al.

BMC Cancer, Journal Year: 2024, Volume and Issue: 24(1)

Published: July 7, 2024

Pancreatic Ductal Adenocarcinoma (PDAC) is an aggressive cancer characterized by immunosuppressive microenvironment. Patients from specific ethnicities and population groups have poorer prognoses than others. Therefore, a better understanding of the immune landscape in such necessary for disease elucidation, predicting patient outcomes therapeutic targeting. This study investigated expression circulating key cell markers South African PDAC patients ancestry.

Language: Английский

Citations

0